James Empfield
Corporate Officer/Principal bei XENON PHARMACEUTICALS INC.
Vermögen: 380 700 $ am 31.05.2024
Profil
James R.
Empfield is currently the Secretary & Director at Xenon Pharmaceuticals USA, Inc. and the Executive Vice President-Drug Discovery at Xenon Pharmaceuticals, Inc. He previously worked as the Director-CNS Chemistry Department at AstraZeneca Pharmaceuticals LP in 2006 and as the Head-Research at Vertex Pharmaceuticals, Inc. from 2011 to 2015.
Dr. Empfield holds a doctorate degree from the University of Pennsylvania, a graduate degree from Bucknell University, and an undergraduate degree from Lebanon Valley College.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
11.03.2024 | 10 000 ( 0,01% ) | 380 700 $ | 31.05.2024 |
Aktive Positionen von James Empfield
Unternehmen | Position | Beginn |
---|---|---|
XENON PHARMACEUTICALS INC. | Corporate Officer/Principal | 01.02.2016 |
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von James Empfield
Unternehmen | Position | Ende |
---|---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.08.2015 |
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Corporate Officer/Principal | 01.01.2006 |
Ausbildung von James Empfield
University of Pennsylvania | Doctorate Degree |
Bucknell University | Graduate Degree |
Lebanon Valley College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
XENON PHARMACEUTICALS INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
AstraZeneca Pharmaceuticals LP
AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology AstraZeneca Pharmaceuticals LP develops, manufactures and markets prescription pharmaceutical drugs. It sells products related to gastrointestinal, cardiovascular, neuroscience, respiratory and oncology infections. The company was founded in 1953 and is headquartered in Wilmington, DE. | Health Technology |
Xenon Pharmaceuticals USA, Inc.
Xenon Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Xenon Pharmaceuticals USA, Inc. develops clinical-stage biopharmaceutical products. The company is headquartered in Boston, PA. | Health Technology |